首页>Cancer Chemotherapy and Pharmacology>A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601)
A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601)
作者单位：Department of Gastroenterology/Gastrointestinal Oncology, Kitasato University, East Hospital, 2-1-1[1]Department of Gastroenterology, Kitasato University Hospital, Kanagawa, Japan[2]Division of Gastroenterology, Kanagawa Cancer Center, Kanagawa, Japan[3]
换一批
